Stock Market News

Tandem Diabetes shares upgraded to buy, target raised to $37

Tandem Diabetes shares upgraded to buy, target raised to $37

  On Monday, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) received an upgrade from Stifel, shifting the stock’s rating from Hold to…
Bandwidth COO sells over $146k in company stock

Bandwidth COO sells over $146k in company stock

  Bandwidth Inc. (NASDAQ:BAND), a leading provider of cloud-based communications services, has reported a significant transaction by its Chief Operating…
TruBridge insiders purchase shares worth nearly $1m

TruBridge insiders purchase shares worth nearly $1m

  In a recent flurry of activity, insiders at TruBridge, Inc. (NASDAQ:CPSI), a company specializing in computer programming services, have…
Cerence CEO Stefan Ortmanns sells shares worth over $228,000

Cerence CEO Stefan Ortmanns sells shares worth over $228,000

  Cerence Inc . (NASDAQ:CRNC), a leader in AI-driven speech recognition software, has reported a significant transaction by its Chief…
US SEC seeks $2 billion from Ripple Labs, chief legal officer says

US SEC seeks $2 billion from Ripple Labs, chief legal officer says

FILE PHOTO: The seal of the U.S. Securities and Exchange Commission (SEC) is seen at their headquarters in Washington, D.C.,…
Stoke Therapeutics reports progress in Dravet syndrome treatment

Stoke Therapeutics reports progress in Dravet syndrome treatment

  BEDFORD, Mass. — Stoke Therapeutics, Inc. (NASDAQ:STOK), a biotechnology firm focused on RNA-based medicines for severe diseases, today announced…
Journey medical director Lindsay Rosenwald buys $68k in stock

Journey medical director Lindsay Rosenwald buys $68k in stock

  Journey Medical Corp (NASDAQ:DERM) director Lindsay (NYSE:LNN) Rosenwald has made a significant investment in the company’s stock, according to…
Evercore ISI maintains Apple Outperform with $220 target

Evercore ISI maintains Apple Outperform with $220 target

  On Monday, Evercore ISI, a prominent investment firm, reaffirmed its positive stance on Apple Inc. (NASDAQ:AAPL), maintaining an Outperform…
Oppenheimer: Market top may not develop until 2025

Oppenheimer: Market top may not develop until 2025

Oppenheimer: Market top may not develop until 2025   Oppenheimer analysts said in a wide-ranging research note this week that…
B.Riley maintains Buy rating on Camtek with $102 price target

B.Riley maintains Buy rating on Camtek with $102 price target

  On Monday, B.Riley reaffirmed its Buy rating on Camtek (NASDAQ:CAMT), a global provider of inspection and metrology solutions for…
Кнопка «Наверх»